TC-5214, a nicotinic channel modulator serves as an adjunct treatment for MDD in patients with an inadequate response to initial antidepressant therapies. The Renaissance clinical trial programme consists
The integration of the LifeOnKey EHR with Target eCRF helps the clinical research investigator maintain the original source document or a certified copy. In addition, source data can
The pharmacodiagnostic tests are intended to identify the patients more likely to benefit from treatment with investigational drug candidates under development by Bristol-Myers Squibb. Dakos CEO Lars Holmkvist
NPSP558 is the company’s bioengineered replica of human parathyroid hormone (rhPTH 1-84), which received orphan drug status for the treatment of hypoparathyroidism. REPLACE was a 28-week, double-blind, placebo-controlled
The lotion is a non-steroidal anti-inflammatory prescription product that treats skin disorders, including atopic dermatitis and allergic contact dermatitis. Neosalus Lotion, along with Neosalus Foam and Neosalus Cream,
According to the company, the new product is targeted at health-conscious consumers. Orange flavored Zing!, a powdered beverage mix is said to be all-natural, sugar-free, and is sweetened
Ancor joined Sentinel Capital and Yukon Capital to complete the transaction. Ancor Capital Partners managing partner J Randall Keene said WellSpring represents the 15th acquisition of a healthcare
The study demonstrated that the combination of two oral direct acting anti hepatitis C virus (HCV) compounds (the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127,
Adeona’s wellZin is oral zinc lozenge used to reduce the duration and symptoms of the common cold. The pharma company intends to commercialize the lozenge that contains 13.3
The university is set to enter a five-year contract with the Anticonvulsant Drug Development Program within the National Institutes of Health, therepublic.com reported, citing The Associated Press. Utah
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.